Navigation Links
LSTM and MiP Consortium awarded further $4.5 million
Date:3/5/2009

The Malaria in Pregnancy Consortium, led by the Liverpool School of Tropical Medicine, has been awarded 3.6 million by the European and Developing Countries Clinical Trials Partnership (EDCTP) to undertake research aimed at optimising the use of an antimalarial drug given to prevent malaria in pregnancy in Africa.

Malaria in pregnancy is a major cause of severe maternal anaemia and preventable low birth weight in infants, which greatly increases the risk of infant death, hence pregnant women showing no malaria symptoms are encouraged to take antimalarial drugs to prevent infection. Intermittent preventive treatment (IPTp) has proven highly effective in reducing the adverse effects of malaria infection in pregnant women and improving birth weight (and hence survival rates) in infants. This project is seeking to optimise the regimen of a particular drug, sulphadoxine-pyrimethamine or SP, which is used widely as IPTp and is looking at alternative approaches to IPTp.

Consortium leader and project co-ordinator Professor Feiko ter Kuile from the Liverpool School of Tropical Medicine explained the significance and future relevance of the activities: "SP is one of the main antimalarials used for the control of malaria in pregnancy, but despite ten years of widespread use, uncertainties about the optimal dose remain. This project will allow us to explore whether pregnant women need a different dose than non-pregnant women because of changes in the way the drug is assimilated during pregnancy.

"It will also allow us to determine whether alternative drug based approaches to control malaria in pregnancy are feasible when the mother is successfully using an insecticide treated bednet to protect her from mosquito bites. The results of this research will be used to inform WHO policy recommendations on the use of SP."

The project involves four European partners in the UK, Austria and Denmark and five African institutions in Malawi, Ghana, The Gambia, Mali and Burkina Faso. It will include a significant element of capacity building in the African host nations, including infrastructural upgrading of five research sites in Africa and a series of short term training courses in clinical trial methodology, research ethics, statistics and research management. Longer term training will involve MSc studentships and PhD scholarships.

The project is part of the global Malaria in Pregnancy (MiP) Consortium's 5-year research agenda and is closely linked with two companion MiP projects also funded by EDCTP, led by MiP Consortium members the Centre for International Health Research, Barcelona and the Prince Leopold Institute of Tropical Medicine, Antwerp.


'/>"/>

Contact: Alan Hughes
a.p.hughes@liv.ac.uk
Liverpool School of Tropical Medicine
Source:Eurekalert

Related medicine news :

1. Autism Consortium releases data on genes involved in autism to researchers worldwide
2. UMass Consortium awarded $300,000 from Juvenile Diabetes Research Foundation and Iacocca Foundation
3. Elan Pharmaceuticals Joins GeneGos MetaTox Consortium
4. Consortium Health Plans Cuts Down on Power Usage and Cooling in Its Data Center Using ONStors Green Clustered NAS Solution
5. Gordon & Rees LLP Joins ArlenGroup-CIGNA Health Care Purchasing Consortium
6. International consortium announces the 1000 Genomes Project
7. Cancer Vaccine Consortium and Cancer Vaccine Collaborative unite under the Cancer Research Institute
8. Geriatric Oncology Consortium (GOC) Announces Tampa Bay Road Rally to Raise Awareness for the Treatment of Seniors With Cancer
9. Siemens Consortium to Construct Particle Therapy Center at the University Clinic of Schleswig-Holstein
10. SAE-Funded CAESAR(TM) Project Earns Federal Laboratory Consortium Award
11. Neuroscience Peer Review Consortium announces increased journal participation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: